¿¬¼ö°­ÁÂ
(¿Â¶óÀÎ) 2021 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ : 2021-04-01
(¿Â¶óÀÎ) 2021 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ : 2021-04-01
±³À°ÀÏÀÚ : 2021-04-01
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ(18.7 ¸íĪº¯°æ ´ëÇÑÈ­Çпä¹ýÇÐȸ)
´ã´çÀÚ : ¹Ú½ÂÀ±
¿¬¶ôó : 02-557-1755  
À̸ÞÀÏ : ksc@ksac.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í Á¤È¸¿ø Àü°øÀÇ 5¸¸¿ø, ÀüÀÓÀÇ 8¸¸¿ø, Àü¹®ÀÇ ÀÏ¹Ý 10¸¸¿ø ºñȸ¿ø Àü°øÀÇ 7¸¸¿ø, ÀüÀÓÀÇ 10¸¸¿ø, Àü¹®ÀÇ ÀÏ¹Ý 12¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ09:00~09:30 Dealing with prosthetic joint infections  ¹Ú°æÈ­(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ09:30~10:00 Dealing with bone and joint infection (non-prosthetic)  ¹Ú±âÈ£(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ10:10~10:40 Antimicrobial stewardship program  ±èÈ«ºó(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ10:40~11:10 Infection control and prevention  ¹ÚÀ±¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ11:10~11:40 Surveillance system  Á¤µÎ·Ã(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ11:50~12:40 A new treatment opportunity in the fight against invasive fungal infections: Isavuconazole in Clinical Setting  TBA(TBA) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ13:30~14:00 TDM for vancomycin and teicoplanin  Á¤Àº°æ(°æÈñ´ë¾à´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ14:00~14:30 TDM for antifungal agents  À̵¿°Ç(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ14:30~15:00 Clinical trials in therapeutic dose monitoring  ¹Ú¿Ï¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ16:30~17:00 Antimicrobial stewardship for pediatric patients: focus on respiratory infections  Àºº´¿í(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ17:00~17:30 Advances in antibacterial resistance testing and diagnosis for antimicrobial stewardship  ±èÅüö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ17:30~18:00 Collaborative antimicrobial stewardship  ÃÖÁØ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ ¿Â¶óÀΠ18:10~19:00 Weight Gain and Metabolic Complications with ARTs: data from CROI 2021  TBA(TBA) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[ºÎ»ê] 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17

±³À°ÀÏÀÚ : 2024-04-17 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : °­ÈÆ ¿¬¶ôó

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,479 , ´ñ±Û¼ö : 0

[¼­¿ï] 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20

±³À°ÀÏÀÚ : 2024-04-20 ±³À°Àå¼Ò : °­µ¿°æÈñ´ëÇб³º´¿ø º°°üµ¿ 4Ãþ Â÷ÈÄ¿µÈ¦ ±³À°ÁÖÁ¦ : 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : °­µ¿°æÈñ´ëÇб³º´¿ø ½Ã

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,305 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï ±³À°ÁÖÁ¦ : SICEM 2024(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ ´ã´çÀÚ : ¹Ú¼öºó ¿¬¶ôó : 02-2038-0

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,483 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (4¿ù) : 2024-04-20

±³À°ÀÏÀÚ : 2024-04-20 ±³À°Àå¼Ò : ¿Â¶óÀÎ (24½Ã°£ VOD ´çÀÏ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (4¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,464 , ´ñ±Û¼ö : 1

[¼­¿ï] (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28

±³À°ÀÏÀÚ : 2024-04-28 ±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ ´ã´çÀÚ : ÃÖÀ±Áö ¿¬¶ôó : 02-6941-087

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,429 , ´ñ±Û¼ö : 0